$1.8B Alios Sale Marks Latham's 2nd Major Deal This Week
Latham & Watkins LLP cemented its strong start to the week with its second billion-dollar deal in as many days, saying Tuesday that it steered viral disease specialist Alios BioPharma Inc....To view the full article, register now.
Already a subscriber? Click here to view full article